RPID beats on revenue but EPS miss looms over Q1 print
Rapid Micro Biosystems just filed its Q1 2026 results with a split scorecard — revenue came in ahead of estimates at $8.0M against a $7.6M consensus, but the loss per share widened sharply to $0.31, missing the $0.23…
